NCT06399744View on ClinicalTrials.gov

Role of Sclerotherapy in Treatment of Non-neoplastic Ovarian Cyst

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

January 30, 2024

Study Completion Date

February 28, 2024

Conditions
Benign Ovarian Cyst
Interventions
PROCEDURE

sclerotherapy

injection of sclerosing agent (tetracycline or polidocanol) into ovarian cyst after aspiration of its contents

Trial Locations (1)

Unknown

Al-Azhar University, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER